(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are CELYAD ONCOLOGY, TARGOVAX, and PROACTIS SA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| CELYAD ONCOLOGY (CYAD.BR) | 0.87 | 8.61% | 2023-03-28 11:08:29 |
| TARGOVAX (TRVX.OL) | 0.71 | 8.18% | 2023-03-28 11:35:47 |
| PROACTIS SA (PROAC.PA) | 0.12 | 8.18% | 2023-03-28 11:02:07 |
| SHELF DRILLING (SHLF.OL) | 25.15 | 6.79% | 2023-03-28 11:34:32 |
| PGS (PGS.OL) | 8.98 | 6.08% | 2023-03-28 11:33:08 |
| PCAS (PCA.PA) | 6.88 | 5.85% | 2023-03-28 11:01:41 |
| ESSO (ES.PA) | 46.00 | 5.75% | 2023-03-28 11:49:06 |
| VIVORYON (VVY.AS) | 14.08 | 5.55% | 2023-03-28 11:06:51 |
| SPBK1 HELGELAND (HELG.OL) | 135.00 | 5.47% | 2023-03-28 11:35:22 |
| DLTX (DLTX.OL) | 1.16 | 5.45% | 2023-03-28 11:24:18 |
The three biggest losers today are BALYO, GRAINES VOLTZ, and MEDIA 6.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| BALYO (BALYO.PA) | 0.57 | -20.92% | 2023-03-28 08:45:17 |
| GRAINES VOLTZ (GRVO.PA) | 52.00 | -15.31% | 2023-03-28 11:51:52 |
| MEDIA 6 (EDI.PA) | 7.75 | -9.88% | 2023-03-28 11:00:16 |
| CADELER (CADLR.OL) | 38.40 | -9.77% | 2023-03-28 11:24:02 |
| SCHIBSTED SER. A (SCHA.OL) | 186.00 | -9% | 2023-03-28 11:34:12 |
| GC RIEBER SHIPPING (RISH.OL) | 15.90 | -8.88% | 2023-03-28 11:30:07 |
| SCHIBSTED SER. B (SCHB.OL) | 177.60 | -8.17% | 2023-03-28 11:34:15 |
| ORPEA (ORP.PA) | 1.96 | -6.9% | 2023-03-28 11:01:24 |
| VOW (VOW.OL) | 13.18 | -6.86% | 2023-03-28 11:36:36 |
| ENSURGE MICROPOWER (ENSU.OL) | 0.25 | -6.26% | 2023-03-28 11:24:54 |
Winners today
1. CELYAD ONCOLOGY (CYAD.BR)
8.61% Price Change
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. The company's preclinical candidate includes CYAD-203, a non-gene edited allogeneic CAR-T candidate to co-express the cytokine interleukin-18 with natural killer group 2D ligands (NKG2D) for the treatment of solid tumors. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery Group plc for the use of its shRNA technology to generate second non-gene-edited allogeneic platform. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with CELYAD ONCOLOGY jumping 8.61% to €0.87 on Tuesday, following the last session’s downward trend. BEL 20 jumped 0.1% to €3,667.16, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.234.
Volume
Today’s last reported volume for CELYAD ONCOLOGY is 2093 which is 98.22% below its average volume of 117953.
More news about CELYAD ONCOLOGY.
2. TARGOVAX (TRVX.OL)
8.18% Price Change
Targovax ASA, a clinical stage immuno-oncology company, engages in the development of immune activators to target hard-to-treat solid tumors. Its lead product candidate is ONCOS-102, which is in Phase I/II clinical trials for the treatment of mesothelioma, melanoma, and colorectal cancer. The company is also developing neoantigen vaccines targeting mutant KRAS cancers. In addition, it is developing ONCOS-211 for next generation ONCOS viruses. The company has collaboration agreements with Cancer Research Institute and Ludwig Cancer Research to develop ONCOS-102 for colorectal cancer with peritoneal carcinomatosis; Valo Therapeutics to develop mutant RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology; and Papyrus Therapeutics to develop novel ONCOS viruses with Receptor Tyrosine Kinase inhibitor functionality. Targovax ASA was incorporated in 2010 and is based in Lysaker, Norway.
Oslo Børs Benchmark Index_GI ended the session with TARGOVAX jumping 8.18% to €0.71 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.07% to €1,159.63, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, TARGOVAX has a trailing twelve months EPS of kr-1.402.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -27.32%.
Volume
Today’s last reported volume for TARGOVAX is 415676 which is 64.91% below its average volume of 1184660.
More news about TARGOVAX.
3. PROACTIS SA (PROAC.PA)
8.18% Price Change
Proactis SA provides source-to-pay software solution. It operates software platform that will give control over business spend. It also offers procurement solutions that provide purchasing professionals with the tools they need for purchasing process for routine goods and services, capital goods, and major projects. In addition, it offers invoice capture services, system administration, supplier onboarding, and tail spent management services. Further, Its solutions integrate with various ERP or financial systems. The company was formerly known as HUBWOO and changed its name to Proactis SA in January 2019. The company is based in Suresnes, France. Proactis SA operates as a subsidiary of Proactis Euro Hedgeco Limited.
CAC 40 ended the session with PROACTIS SA jumping 8.18% to €0.12 on Tuesday while CAC 40 rose 0.14% to €7,088.34.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.69%.
Volume
Today’s last reported volume for PROACTIS SA is 1000 which is 94.07% below its average volume of 16871.
Yearly Top and Bottom Value
PROACTIS SA’s stock is valued at €0.12 at 22:40 EST, way under its 52-week high of €0.15 and way above its 52-week low of €0.08.
Moving Average
PROACTIS SA’s worth is above its 50-day moving average of €0.12 and above its 200-day moving average of €0.12.
More news about PROACTIS SA.
4. SHELF DRILLING (SHLF.OL)
6.79% Price Change
Shelf Drilling, Ltd., together with its subsidiaries, operates as a shallow water offshore drilling contractor in the Middle East, North Africa, the Mediterranean, Southeast Asia, India, West Africa, and North Sea. The company offers equipment and services for the drilling, completion, maintenance, and decommissioning of oil and natural gas wells. It serves government owned or controlled energy companies, and publicly listed global integrated oil companies or independent exploration and production companies. The company owns 36 independent-leg cantilever jack-up rigs. Shelf Drilling, Ltd. was incorporated in 2012 and is headquartered in Dubai, the United Arab Emirates.
Oslo Børs Benchmark Index_GI ended the session with SHELF DRILLING jumping 6.79% to €25.15 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.07% to €1,159.63.
Earnings Per Share
As for profitability, SHELF DRILLING has a trailing twelve months EPS of kr-16.75.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.15%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SHELF DRILLING’s EBITDA is 290.8.
More news about SHELF DRILLING.
5. PGS (PGS.OL)
6.08% Price Change
PGS ASA, together with its subsidiaries, operates as a marine geophysical company primarily in Norway. The company provides a range of seismic and reservoir services, including data acquisition, imaging, interpretation, and field evaluation to oil and gas companies. It also operates in the Asia Pacific, Canada, Egypt, the Americas, Angola, the United Kingdom, Ukraine, Brazil, South Africa, other African countries, the Middle East, and internationally. The company was formerly known as Petroleum Geo-Services ASA and changed its name to PGS ASA in May 2019. PGS ASA was founded in 1991 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PGS jumping 6.08% to €8.98 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.07% to €1,159.63, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, PGS has a trailing twelve months EPS of kr-5.26.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.68%.
Volume
Today’s last reported volume for PGS is 15571900 which is 31.21% below its average volume of 22639400.
Moving Average
PGS’s worth is under its 50-day moving average of kr9.65 and way above its 200-day moving average of kr7.48.
More news about PGS.
6. PCAS (PCA.PA)
5.85% Price Change
PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS
CAC 40 ended the session with PCAS rising 5.85% to €6.88 on Tuesday, following the last session’s upward trend. CAC 40 jumped 0.14% to €7,088.34, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, PCAS has a trailing twelve months EPS of €-4.92.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -220.55%.
More news about PCAS.
7. ESSO (ES.PA)
5.75% Price Change
Esso S.A.F. refines, distributes, and markets refined petroleum products in France and internationally. The company's refining products include gas, gasoline, fuels and combustibles, and bitumens; petrochemical products, such as steam cracking, intermediate products, polyethylene, polypropylene, Escorez, additives for petroleum products, and Vistalon. It also manufactures and sells base oils, finished lubricants, white oils, and paraffins. In addition, the company operates a network of service stations under the Esso and Esso Express brands, as well as provides greases. It offers fuels under the Esso brand name and lubricants under the Mobil brand. The company markets its products through a network of authorized distributors, resellers, and directly to industrial accounts. Esso S.A.F. was founded in 1902 and is headquartered in Nanterre, France. Esso S.A.F. is a subsidiary of ExxonMobil France Holding S.A.S.
CAC 40 ended the session with ESSO rising 5.75% to €46.00 on Tuesday, after three consecutive sessions in a row of losses. CAC 40 jumped 0.14% to €7,088.34, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, ESSO has a trailing twelve months EPS of €-48.72.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 117.35%.
More news about ESSO.
8. VIVORYON (VVY.AS)
5.55% Price Change
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a small molecule QC inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease; and for the treatment of cancer. Its preclinical development product is PQ1565, a small molecule glutaminyl-peptide cyclotransferase-like inhibitor for the treatment of cancer. In addition, the company is developing a monoclonal antibody targeting pGlu-Abeta to enhance its clearance. Vivoryon Therapeutics N.V. has a research collaboration agreement with University Medical Center Schleswig-Holstein to discover and develop therapeutics in cancer immunotherapy; collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
AEX-Index ended the session with VIVORYON jumping 5.55% to €14.08 on Tuesday while AEX-Index fell 0.29% to €733.81.
Earnings Per Share
As for profitability, VIVORYON has a trailing twelve months EPS of €-0.83.
Volume
Today’s last reported volume for VIVORYON is 93569 which is 29.16% above its average volume of 72440.
Volatility
VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.54%, a negative 0.71%, and a positive 2.52%.
VIVORYON’s highest amplitude of average volatility was 4.54% (last week), 2.80% (last month), and 2.52% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VIVORYON’s stock is considered to be overbought (>=80).
More news about VIVORYON.
9. SPBK1 HELGELAND (HELG.OL)
5.47% Price Change
SpareBank 1 Helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in Norway. The company operates in two segments, Retail Market and Corporate Market. It offers savings, investment, and insurance products, as well as leasing and mortgage services. The company also engages in owning, managing, letting, buying, and selling commercial properties. It operates through three branches located in Mosjøen, Brønnøysund, and Sandnessjøen. The company was founded in 1860 and is headquartered in Mo i Rana, Norway.
Oslo Børs Benchmark Index_GI ended the session with SPBK1 HELGELAND jumping 5.47% to €135.00 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.07% to €1,159.63.
Earnings Per Share
As for profitability, SPBK1 HELGELAND has a trailing twelve months EPS of kr12.
PE Ratio
SPBK1 HELGELAND has a trailing twelve months price to earnings ratio of 11.25. Meaning, the purchaser of the share is investing kr11.25 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 10.26 and the estimated forward annual dividend yield is 7.33%.
Sales Growth
SPBK1 HELGELAND’s sales growth is 21.8% for the present quarter and 24% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 33.3% and 84.5%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 79.2%, now sitting on 959M for the twelve trailing months.
More news about SPBK1 HELGELAND.
10. DLTX (DLTX.OL)
5.45% Price Change
DLT ASA, a technology company, invests in distributed ledger technology and blockchain sectors. It engages in the provision of commercial business, physical infrastructure, and software services. The company is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with DLTX rising 5.45% to €1.16 on Tuesday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.07% to €1,159.63, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DLTX’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for DLTX is 216585 which is 61.83% below its average volume of 567430.
More news about DLTX.
Losers Today
1. BALYO (BALYO.PA)
-20.92% Price Change
Balyo SA designs, develops, and markets material handling robots worldwide. The company offers robotic pallet and reach trucks, tuggers, stackers, counterbalanced stackers, very narrow aisles, and autonomous mobile robots. Its products are used in intelligent pallet detection, barcode scanning, inter-building transport, push button configuration, machine interface, ERP interfacing, and palletizers; and WMS interface and 3D camera applications. The company serves 3PL, automotive, e-commerce, and consumer goods industries. Balyo SA was founded in 2004 and is headquartered in Arcueil, France.
CAC 40 ended the session with BALYO dropping 20.92% to €0.57 on Tuesday while CAC 40 jumped 0.14% to €7,088.34.
Earnings Per Share
As for profitability, BALYO has a trailing twelve months EPS of €-0.28.
Volatility
BALYO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.91%, a negative 0.84%, and a positive 3.95%.
BALYO’s highest amplitude of average volatility was 6.69% (last week), 4.44% (last month), and 3.95% (last quarter).
More news about BALYO.
2. GRAINES VOLTZ (GRVO.PA)
-15.31% Price Change
Graines Voltz S.A. engages in the distribution of seeds, vegetable plants, and flower bulbs to professionals, horticulturists, market gardeners, and communities in France, rest of Europe, the Middle East, Africa, and internationally. It also produces seeds and young horticultural plants. The company was founded in 1985 and is headquartered in Colmar, France.
CAC 40 ended the session with GRAINES VOLTZ dropping 15.31% to €52.00 on Tuesday while CAC 40 rose 0.14% to €7,088.34.
Earnings Per Share
As for profitability, GRAINES VOLTZ has a trailing twelve months EPS of €3.26.
PE Ratio
GRAINES VOLTZ has a trailing twelve months price to earnings ratio of 15.97. Meaning, the purchaser of the share is investing €15.97 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GRAINES VOLTZ’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for GRAINES VOLTZ is 8531 which is 1070.23% above its average volume of 729.
More news about GRAINES VOLTZ.
3. MEDIA 6 (EDI.PA)
-9.88% Price Change
Groupe MEDIA 6, a point-of-purchase (POP) advertising company, provides multi-material solutions in France and internationally. The company offers hydro-alcoholic gel dispensing column with PMR access options, counter displays, plexiglass protective barriers, protective visors, and floor markings; merchandising management services; point-of-purchase marketing; installs furniture, shop windows, podiums, and communication materials; and processes cardboard, wood, metal, and plastic products. It also provides experiential marketing, POP displays, shop fixtures, shop fittings, pharmacy fittings, trade marketing, and POP display for coloration, as well as operates art workshop. In addition, it offers various tools for the customization of sales accessories, product racks, bag and shoe doors, presentation trays, articulated hands, wooden feet and head, and busts and displays for shops. The company was founded in 1977 and is based in Tremblay-en-France, France. Groupe MEDIA 6 is a subsidiary of VASCO SARL.
CAC 40 ended the session with MEDIA 6 falling 9.88% to €7.75 on Tuesday, after five successive sessions in a row of losses. CAC 40 jumped 0.14% to €7,088.34, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, MEDIA 6 has a trailing twelve months EPS of €0.18.
PE Ratio
MEDIA 6 has a trailing twelve months price to earnings ratio of 43.06. Meaning, the purchaser of the share is investing €43.06 for every euro of annual earnings.
More news about MEDIA 6.
4. CADELER (CADLR.OL)
-9.77% Price Change
Cadeler A/S operates as an offshore wind farm transportation and installation contractor in Denmark. The company also provides wind farm maintenance, construction, decommissioning, and other tasks within the offshore industry. It owns and operates two offshore jack-up windfarm installation vessels. The company was formerly known as Swire Blue Ocean A/S and changed its name to Cadeler A/S in October 2020. Cadeler A/S was founded in 2008 and is headquartered in Copenhagen, Denmark.
Oslo Børs Benchmark Index_GI ended the session with CADELER falling 9.77% to €38.40 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.07% to €1,159.63, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, CADELER has a trailing twelve months EPS of kr-10.43.
Volume
Today’s last reported volume for CADELER is 197990 which is 29.67% above its average volume of 152685.
More news about CADELER.
5. SCHIBSTED SER. A (SCHA.OL)
-9% Price Change
Schibsted ASA, together with its subsidiaries, operates as a media company. The company operates through Nordic Marketplaces, News Media, eCommerce & Distribution, and Financial Services & Ventures segments. It operates online classified operations that provide technology-based services to connect buyers and sellers and facilitate transactions from job offers to real estate, cars, travel, consumer goods, and others. The company also offers news brands, such as VG, Aftenposten, Bergens Tidende, Aftonbladet, and Svenska Dagbladet in paper and digital formats, as well as operates printing plant. In addition, the company distributes newspapers and parcels for businesses and consumers under the Helthjem and Morgenlevering brands. Further, it has a portfolio of digital companies, which include Lendo that offers digital marketplaces for consumer lending; and Prisjakt, which offers price comparison for consumers. The company operates in Norway, Sweden, Finland, Denmark, other European countries, and internationally. Schibsted ASA was founded in 1839 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with SCHIBSTED SER. A dropping 9% to €186.00 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.07% to €1,159.63, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, SCHIBSTED SER. A has a trailing twelve months EPS of kr3.66.
PE Ratio
SCHIBSTED SER. A has a trailing twelve months price to earnings ratio of 50.75. Meaning, the purchaser of the share is investing kr50.75 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.72%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.3%, now sitting on 15.27B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 2, 2023, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 0.95%.
Sales Growth
SCHIBSTED SER. A’s sales growth for the current quarter is 1.7%.
More news about SCHIBSTED SER. A.
6. GC RIEBER SHIPPING (RISH.OL)
-8.88% Price Change
GC Rieber Shipping ASA operates as a ship owner and project house with a focus on developing maritime projects in Norway and internationally. It also provides services for scientific expeditions and logistics operations, as well as services to the oil and gas sector. The company was founded in 1879 and is headquartered in Bergen, Norway. GC Rieber Shipping ASA is a subsidiary of GC Rieber AS.
Oslo Børs Benchmark Index_GI ended the session with GC RIEBER SHIPPING falling 8.88% to €15.90 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.07% to €1,159.63.
Earnings Per Share
As for profitability, GC RIEBER SHIPPING has a trailing twelve months EPS of kr0.44.
PE Ratio
GC RIEBER SHIPPING has a trailing twelve months price to earnings ratio of 36.14. Meaning, the purchaser of the share is investing kr36.14 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.94%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
GC RIEBER SHIPPING’s EBITDA is 22.32.
Volume
Today’s last reported volume for GC RIEBER SHIPPING is 84603 which is 212.21% above its average volume of 27098.
Volatility
GC RIEBER SHIPPING’s last week, last month’s, and last quarter’s current intraday variation average was 7.32%, 1.45%, and 3.44%.
GC RIEBER SHIPPING’s highest amplitude of average volatility was 8.90% (last week), 3.76% (last month), and 3.44% (last quarter).
More news about GC RIEBER SHIPPING.
7. SCHIBSTED SER. B (SCHB.OL)
-8.17% Price Change
Schibsted ASA, together with its subsidiaries, operates as a media company. The company operates through Nordic Marketplaces, News Media, eCommerce & Distribution, and Financial Services & Ventures segments. It operates online classified operations that provide technology-based services to connect buyers and sellers and facilitate transactions from job offers to real estate, cars, travel, consumer goods, and others. The company also offers news brands, such as VG, Aftenposten, Bergens Tidende, Aftonbladet, and Svenska Dagbladet in paper and digital formats, as well as operates printing plant. In addition, the company distributes newspapers and parcels for businesses and consumers under the Helthjem and Morgenlevering brands. Further, it has a portfolio of digital companies, which include Lendo that offers digital marketplaces for consumer lending; and Prisjakt, which offers price comparison for consumers. The company operates in Norway, Sweden, Finland, Denmark, other European countries, and internationally. Schibsted ASA was founded in 1839 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with SCHIBSTED SER. B dropping 8.17% to €177.60 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.07% to €1,159.63, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, SCHIBSTED SER. B has a trailing twelve months EPS of kr3.66.
PE Ratio
SCHIBSTED SER. B has a trailing twelve months price to earnings ratio of 48.46. Meaning, the purchaser of the share is investing kr48.46 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.72%.
Moving Average
SCHIBSTED SER. B’s value is way under its 50-day moving average of kr203.03 and higher than its 200-day moving average of kr175.10.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SCHIBSTED SER. B’s EBITDA is 94.71.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.3%, now sitting on 15.27B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 2, 2023, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 1.01%.
More news about SCHIBSTED SER. B.
8. ORPEA (ORP.PA)
-6.9% Price Change
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.
CAC 40 ended the session with ORPEA dropping 6.9% to €1.96 on Tuesday, after two successive sessions in a row of losses. CAC 40 jumped 0.14% to €7,088.34, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, ORPEA has a trailing twelve months EPS of €-4.11.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.36%.
Moving Average
ORPEA’s value is way under its 50-day moving average of €3.75 and way under its 200-day moving average of €12.01.
Sales Growth
ORPEA’s sales growth is 9% for the ongoing quarter and 9% for the next.
More news about ORPEA.
9. VOW (VOW.OL)
-6.86% Price Change
Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, Canada, and Italy. It operates in three segments: Projects Cruise, Aftersales, and Landbased. The Projects Cruise segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; advanced systems to shipowners for ships; and systems for aquaculture sludge treatment. The Aftersales segment provides spare parts and consumables; chemicals; and tailor-made service and maintenance programs. The Landbased segment offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. The company serves cruise, aquaculture, and landbased industries, as well as utilities. It has a strategic partnership agreement with Repsol, S.A. to explore applications and solutions to produce clean and renewable energy for CO2 emission reduction. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was incorporated in 2011 and is headquartered in Lysaker, Norway.
Oslo Børs Benchmark Index_GI ended the session with VOW dropping 6.86% to €13.18 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.07% to €1,159.63.
Earnings Per Share
As for profitability, VOW has a trailing twelve months EPS of kr0.26.
PE Ratio
VOW has a trailing twelve months price to earnings ratio of 50.89. Meaning, the purchaser of the share is investing kr50.89 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 63.6%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 98.6%, now sitting on 652.6M for the twelve trailing months.
Moving Average
VOW’s worth is way below its 50-day moving average of kr18.43 and way under its 200-day moving average of kr19.91.
More news about VOW.
10. ENSURGE MICROPOWER (ENSU.OL)
-6.26% Price Change
Ensurge Micropower ASA designs, develops, and produces ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries with high energy densities. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER dropping 6.26% to €0.25 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.07% to €1,159.63, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-0.345.
Volatility
ENSURGE MICROPOWER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.04%, a positive 0.11%, and a positive 7.70%.
ENSURGE MICROPOWER’s highest amplitude of average volatility was 3.90% (last week), 7.74% (last month), and 7.70% (last quarter).
More news about ENSURGE MICROPOWER.
Stay up to date with our winners and losers daily report
